FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

407317001: Adalimumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2151148012 Adalimumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2158924011 Adalimumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
2151148012 Adalimumab (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2151148012 Adalimumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2158924011 Adalimumab en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2158924011 Adalimumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
56931000195118 adalimumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
72011000195112 Adalimumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
193121000077110 adalimumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
193121000077110 adalimumab fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
56931000195118 adalimumab it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
72011000195112 Adalimumab de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Adalimumab Is a agent d'anticorps monoclonal false Inferred relationship Existential restriction modifier (core metadata concept)
Adalimumab Is a agent antirhumatismal false Inferred relationship Existential restriction modifier (core metadata concept)
Adalimumab Is a Substance with tumor necrosis factor alpha inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Adalimumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier (core metadata concept)
Adalimumab Has disposition Tumor necrosis factor alpha inhibitor true Inferred relationship Existential restriction modifier (core metadata concept)
Adalimumab Is a Immunologic agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
adalimumab 40mg injection solution 0.8mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adalimumab Inferred relationship Existential restriction modifier (core metadata concept)
Product containing adalimumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Adalimumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Adalimunab 40mg/mL injection solution 1mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Adalimumab Inferred relationship Existential restriction modifier (core metadata concept)
Adalimumab therapy (procedure) Direct substance True Adalimumab Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely adalimumab 40 milligram/0.8 milliliter conventional release solution for injection syringe Has precise active ingredient False Adalimumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely adalimumab 40 milligram/0.8 milliliter conventional release solution for injection syringe Has basis of strength substance (attribute) False Adalimumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing adalimumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Adalimumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing only adalimumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Adalimumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Adalimumab only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Adalimumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Adalimumab 50 mg/mL solution for injection Has basis of strength substance (attribute) True Adalimumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Adalimumab 50 mg/mL solution for injection Has precise active ingredient True Adalimumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely adalimumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Adalimumab Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely adalimumab 100 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance (attribute) True Adalimumab Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start